|
|
|
By Faisal Mohammad Shamim Khan, University of South Florida | BCS Class IV drugs have low solubility and permeability. Oral nanoparticles can overcome both barriers, offering a more effective and tunable oral delivery strategy. | |
|
|
Delivery Device Selection For Biologics | By Drug Delivery Leader Live | At the Drug Delivery Leader Live online event on large molecule delivery, panelist Dominick DeGrazio outlined key considerations, including technical requirements, compatibility, regulatory, quality, and supply chain. |
|
|
|
| 6 Strategic Pillars For Drug Delivery Success | Article | By Scott Mills and Armando Pedoto, Sr., Adare Pharma Solutions | Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch. |
|
|
| GLP-1s: From I.V. To Sub Q And Inhaled Delivery | Webinar | Nanoform | Developing new delivery routes is essential for creating more effective treatments. Nano forming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs. |
|
|
| Redefining Prefillable Syringe System | Infographic | West Pharmaceutical Services, Inc. | This step-by-step flow helps guide teams from early feasibility assessments all the way through to regulatory submission, with greater clarity at each stage. |
|
|
|
|
.png){kind=logo}
